LQDA FY 2024 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$14M-20.0% YoY

Gross Profit

$8M58.0% margin

Operating Income

-$121M-866.6% margin

Net Income

-$130M-931.7% margin

EPS (Diluted)

$-1.66

Cash Flow

Operating Cash Flow

-$93M

Free Cash Flow

-$98M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$230M

Total Liabilities

$153M

Stockholders' Equity

$77M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$17M	-20.0%
Gross Profit	$8M	$15M	-44.4%
Operating Income	-$121M	-$73M	-65.3%
Net Income	-$130M	-$79M	-66.1%